» Articles » PMID: 29731627

Gold Nanoparticle-based Colorimetric Method for the Detection of Prostate-specific Antigen

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2018 May 8
PMID 29731627
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prostate-specific antigen (PSA), a serine protease, is a biomarker for preoperative diagnosis and screening of prostate cancer and monitoring of its posttreatment.

Methods: In this work, we reported a colorimetric method for clinical detection of PSA using gold nanoparticles (AuNPs) as the reporters. The method is based on ascorbic acid (AA)-induced in situ formation of AuNPs and Cu-catalyzed oxidation of AA. Specifically, HAuCl can be reduced into AuNPs by AA; Cu ion can catalyze the oxidation of AA by O to inhibit the formation of AuNPs. In the presence of the PSA-specific peptide (DASSKLQLAPP)-modified gold-coated magnetic microbeads (MMBs; denoted as DASSKLQLAPP-MMBs), complexation of Cu by the MMBs through the DAH-Cu interaction depressed the catalyzed oxidation of AA and thus allowed for the formation of red AuNPs. However, once the peptide immobilized on the MMB surface was cleaved by PSA, the DASSKLQ segment would be released. The resultant LAPP fragment remaining on the MMB surface could not sequestrate Cu to depress its catalytic activity toward AA oxidation. Consequently, no or less AuNPs were generated.

Results: The linear range for PSA detection was found to be 0~0.8 ng/mL with a detection limit of 0.02 ng/mL. Because of the separation of cleavage step and measurement step, the interference of matrix components in biological samples was avoided.

Conclusion: The high extinction coefficient of AuNPs facilitates the colorimetric analysis of PSA in serum samples. This work is helpful for designing of other protease biosensors by matching specific peptide substrates.

Citing Articles

Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer.

Ivanov Y, Malsagova K, Goldaeva K, Kapustina S, Pleshakova T, Popov V Sensors (Basel). 2023; 23(17).

PMID: 37687982 PMC: 10490786. DOI: 10.3390/s23177527.


Development of label-free gold nanoparticle based rapid colorimetric assay for clinical/point-of-care screening of cervical cancer.

Appidi T, Mudigunda S, Kodandapani S, Rengan A Nanoscale Adv. 2022; 2(12):5737-5745.

PMID: 36133887 PMC: 9419083. DOI: 10.1039/d0na00686f.


Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates.

Barani M, Sabir F, Rahdar A, Arshad R, Kyzas G Nanomaterials (Basel). 2020; 10(9).

PMID: 32872181 PMC: 7559844. DOI: 10.3390/nano10091696.


Fiber optic sensor based on ZnO nanowires decorated by Au nanoparticles for improved plasmonic biosensor.

Kim H, Park J, Lee S Sci Rep. 2019; 9(1):15605.

PMID: 31666617 PMC: 6821738. DOI: 10.1038/s41598-019-52056-1.

References
1.
Suaifan G, Shehadeh M, Al-Ijel H, Ng A, Zourob M . Recent progress in prostate-specific antigen and HIV proteases detection. Expert Rev Mol Diagn. 2013; 13(7):707-18. DOI: 10.1586/14737159.2013.835576. View

2.
Chen C, Huang C, Chang H . Label-free colorimetric detection of picomolar thrombin in blood plasma using a gold nanoparticle-based assay. Biosens Bioelectron. 2010; 25(8):1922-7. DOI: 10.1016/j.bios.2010.01.005. View

3.
Baron R, Zayats M, Willner I . Dopamine-, L-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: assays for the detection of neurotransmitters and of tyrosinase activity. Anal Chem. 2005; 77(6):1566-71. DOI: 10.1021/ac048691v. View

4.
Suaifan G, Esseghaier C, Ng A, Zourob M . Ultra-rapid colorimetric assay for protease detection using magnetic nanoparticle-based biosensors. Analyst. 2013; 138(13):3735-9. DOI: 10.1039/c3an36881e. View

5.
Ibau C, Md Arshad M, Gopinath S . Current advances and future visions on bioelectronic immunosensing for prostate-specific antigen. Biosens Bioelectron. 2017; 98:267-284. DOI: 10.1016/j.bios.2017.06.049. View